The global pet at-home diagnostic tests market size was estimated at USD 82.14 million in 2026 and is projected to grow at a CAGR of 7.8% from 2026 to 2033, reaching USD 112.8 million in 2033.
The Global Pets Diagnostic Tests Market encompasses all veterinary diagnostic procedures, technologies, and services used to detect diseases, disorders, and health conditions in companion animals including dogs, cats, and exotic pets. It covers laboratory tests, imaging diagnostics, molecular assays (e.g., PCR), immunodiagnostics, and point-of-care testing solutions that support preventive care and clinical decision-making in veterinary practices. Market growth is driven by rising pet ownership, increased spending on animal health, and demand for early disease detection to improve clinical outcomes and extend pet lifespans, supported by advances in diagnostic platforms and integration into routine veterinary care workflows.
Key trends shaping the Pets Diagnostic Tests Market include accelerated adoption of point-of-care and rapid diagnostic solutions, integration of artificial intelligence and cloud-based data analytics for enhanced accuracy and workflow efficiency, and growing utilization of multiplex and molecular testing platforms. A significant trend is the increasing emphasis on preventive veterinary care driven by pet humanization, which fuels demand for comprehensive wellness screening protocols. Also, urban pet healthcare infrastructures and telemedicine enable broader access to diagnostics, while rising zoonotic disease awareness underscores the importance of robust companion animal testing frameworks globally.
Segmentation: The Global Pets Diagnostic Tests Market is segmented by Animal Type (Dogs, Cats and Other Pets (Birds, Rabbits, Reptiles, and Small Mammals), Test Type (Hematology & Biochemistry Tests, Imaging Diagnostics (X-ray, Ultrasound and MRI/CT), Molecular & Genetic Tests, Microbiological & Serological Tests, Urinalysis, and Other Diagnostics (Endoscopy and Allergen testing)), Technology (Point-of-Care (POC) Diagnostics, Laboratory-Based Diagnostics, Automated Diagnostic Systems and Manual/Traditional Methods), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the value (in USD million) for the above segments.
Market Drivers:
Growing global pet ownership, paired with the humanization of companion animals, is a primary driver of diagnostic market expansion. More households view pets as family members, increasing demand for regular wellness checks, early disease detection, and advanced diagnostic care. This trend, amplified by expanding pet insurance coverage and heightened owner willingness to invest in preventive healthcare, directly translates into higher utilization of diagnostic tests across clinics and reference laboratories. Technological improvements and broader education on pet health further reinforce diagnostic spending, shaping sustained market growth.
Rapid technological innovation is another strong market driver for global pet diagnostic tests. The introduction of advanced tools such as point-of-care testing devices, digital imaging (e.g., ultrasound and MRI tailored for animals), and molecular diagnostics like PCR and next-generation sequencing has transformed veterinary care. These technologies enable faster, more accurate diagnoses, improving treatment outcomes for pets. Additionally, integration of telemedicine and portable diagnostic kits makes testing more accessible to remote or underserved areas.
Veterinary clinics and diagnostic labs are increasingly adopting automation, AI-driven analytics, and cloud-based data systems, enhancing efficiency and enabling personalized care for diverse pet populations worldwide. For instance, Vetic, an Indian pet healthcare company, raised USD 26 million in a funding round led by Bessemer Venture Partners in May 2025. The capital was intended to advance pet healthcare and standardize telemedicine and veterinary services in India's Tier 1 and Tier 2 cities.
Market Restraints:
A significant restraint on the global pet diagnostic tests market is the high cost associated with advanced diagnostic procedures and limited pet insurance penetration. Sophisticated tests like MRI, CT scans, and comprehensive genetic panels remain expensive, deterring price-sensitive pet owners—especially in emerging economies. Moreover, pet insurance coverage is still nascent in many regions, meaning most diagnostic costs are paid out-of-pocket. This financial burden can lead owners to delay or forego recommended diagnostic workups, suppressing overall market growth. Additionally, the lack of standardized pricing and reimbursement frameworks across countries further complicates affordability and access to regular diagnostic services for many pet owners.
The market contributes positively to socioeconomic development by bolstering veterinary healthcare infrastructure, creating skilled jobs, and supporting allied industries such as pet insurance and diagnostics manufacturing. As pet ownership rises globally, especially among middle-income households, demand for quality animal healthcare stimulates investments in labs, clinics, and training programs, enhancing community veterinary capacity. Increased diagnostic utilization can also reduce public health risks by facilitating early detection of zoonoses. However, the high cost of diagnostics and limited access in low-income or rural regions can exacerbate health disparities, challenging equitable distribution of veterinary services.
Segmental Analysis:
The dogs segment is anticipated to witness the highest growth in the global pets diagnostic tests market over the forecast period due to rising dog ownership and increasing expenditure on canine healthcare. Dogs are among the most common household pets worldwide, with owners keenly investing in preventive care and early disease detection. Canine-specific diseases—such as orthopedic conditions, heart disease, and infectious illnesses—drive demand for routine diagnostics like blood panels, imaging, and microbiological testing. Additionally, growing awareness of breed-specific health risks and the availability of advanced, dog-tailored diagnostic services contribute to this segment’s expansion. Veterinary practices are also increasingly equipped with dog-optimized diagnostic tools, enhancing both accessibility and market growth.
The microbiological and serological tests segment is projected to experience the highest growth due to heightened demand for accurate detection of infectious diseases in pets. These tests play a critical role in identifying bacterial, viral, and parasitic infections, which remain prevalent among both companion and shelter animals. Increased emphasis on disease surveillance, zoonotic risk mitigation, and preventive healthcare has led veterinarians to rely on microbiological cultures and serological assays. Improvements in test sensitivity and turnaround time further boost adoption. Additionally, outbreaks of contagious diseases like parvovirus or leptospirosis stimulate routine screening and post-treatment monitoring, solidifying this segment’s growth trajectory. Growing veterinary laboratory capacities globally support broader utilization of these diagnostics.
The Point-of-Care (POC) diagnostics segment is set to witness the fastest growth over the forecast period due to the increasing need for rapid, on-site testing in veterinary settings. POC diagnostics enable veterinarians to obtain timely results during a single visit, improving clinical decision-making and enhancing pet outcomes. These portable, user-friendly devices—such as handheld blood analyzers and rapid antigen tests—are particularly valuable in emergency cases and routine wellness checks. Growing adoption of POC solutions in small clinics and mobile veterinary services, especially in regions with limited access to centralized labs, bolsters market expansion. Additionally, technological advancements and declining costs of POC platforms are making them more accessible to a broader range of practices worldwide.
The North American region is expected to witness the highest growth in the global pets diagnostic tests market, driven by strong pet ownership rates and high veterinary healthcare spending. The U.S. and Canada have well-established veterinary infrastructures, advanced laboratory networks, and widespread adoption of cutting-edge diagnostic technologies. For instance, in June 2025, Innovative Pet Lab partnered with Independent Pet Supply Distributors to broaden the distribution of its at-home pet health tests across seven Western and Northwestern U.S. states, including Oregon, Washington, and Alaska.
Pet owners in North America increasingly prioritize preventive care, routine screenings, and early disease detection, fueling demand for comprehensive diagnostic services. For instance, in September 2025, Canada Insurance News, published that over 60% of Canadian households own at least one dog or cat, with the companion animal population exceeding 16 million. Annual veterinary spending averages C$2,500–3,000 per dog and up to C$2,000 per cat. This is prompting North American pet owners to seek preventive and early diagnostics to manage expenses proactively, thereby boosting demand for routine screening and affordable testing solutions and positively influencing growth in the pets diagnostic tests market.
Additionally, the growing availability of pet insurance encourages utilization of higher-cost diagnostic tests. Robust research and development activities, favorable regulatory environments, and an expanding base of specialty veterinary practices further reinforce the region’s leadership in market growth during the forecast period. For instance, Innovative Pet Lab secured USD 1.1 million in Pre-Seed funding in June 2025. The investment was designated to support the development and expansion of its at-home pet health testing kit product line. Thus, all these factors are together driving the growth of this market in this region.
The competitive landscape of the Pets Diagnostic Tests Market is moderately concentrated, with leading companies such as IDEXX Laboratories, Zoetis, and Antech Diagnostics commanding significant market share through extensive product portfolios, global distribution, and strong customer relationships. These players compete on innovation, service networks, consumables supply, and recurring revenue models tied to instrument placements. Market competition also includes specialized molecular diagnostic developers and emerging point-of-care device manufacturers, driving continuous R&D and strategic partnerships to differentiate offerings and capture growth in priority regions such as North America, Europe, and Asia-Pacific.
The major players for this market are:
Recent Development
Q1. What are the main growth-driving factors for this market?
The market is primarily driven by rising pet "humanization," where owners invest more in premium healthcare. Increased prevalence of zoonotic and chronic diseases, such as diabetes and cancer, necessitates frequent testing. Furthermore, advancements in point-of-care (POC) testing and rising awareness regarding preventive veterinary care are significantly boosting global diagnostic demand.
Q2. What are the main restraining factors for this market?
High costs associated with advanced diagnostic imaging and molecular testing act as a major restraint, particularly in emerging economies. Additionally, a shortage of skilled veterinary professionals capable of operating sophisticated equipment and interpreting complex results limits market expansion. Limited reimbursement policies for pet insurance also hinder the adoption of expensive tests.
Q3. Which segment is expected to witness high growth?
The dogs segment is expected to witness the highest growth over the forecast period due to rising dog ownership and increasing spending on canine healthcare. Greater awareness of preventive care, routine health screenings, and early disease detection is driving demand for advanced diagnostic tests. Additionally, the prevalence of breed-specific disorders and aging dog populations further supports sustained growth in this segment.
Q4. Who are the top major players for this market?
Key players dominating the market include IDEXX Laboratories, Inc., Zoetis Inc., and Heska Corporation. These companies lead through continuous innovation and strategic acquisitions. Other significant participants include Mars, Incorporated (Antech Diagnostics), Neogen Corporation, and Thermo Fisher Scientific, all focusing on expanding their diagnostic portfolios and global distribution networks.
Q5. Which country is the largest player?
The United States is the largest player in the pet diagnostics market. Its leadership is fueled by high pet ownership rates, substantial disposable income, and a well-established network of veterinary hospitals. The presence of industry giants like IDEXX and Zoetis further cements its position as the primary hub for innovation.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
